Jay R. Venkatesan

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Jay R. Venkatesan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jay R. Venkatesan:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 2,600,980 $33,136,485 $12.74 15 Jul 2022 By Alpine ImmunoSciences, L.P.
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 238,126 $3,033,725 $12.74 15 Jul 2022 Direct
Serina Therapeutics, Inc. Director Series A Convertible Preferred Stock 96,525 $500,000 $5.18 08 Apr 2025 The Jay Venkatesan Legacy Trust
Elicio Therapeutics, Inc. Director Pre-Funded Warrants 50,000 $249,500 $4.99 28 Jun 2024 Direct
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 18,633 $237,384 $12.74 15 Jul 2022 By Raj Venkatesan as UTMA custodian for Nathaniel Graham Venkatesan
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Common Stock 18,633 $237,384 $12.74 15 Jul 2022 By Raj Venkatesan as UTMA custodian for Reid Coleman Venkatesan
Elicio Therapeutics, Inc. Director Common Stock 179,581 $1,796 $0.0100 26 Nov 2024 Direct
Elicio Therapeutics, Inc. Director Common Stock 953 $10 $0.0100 26 Nov 2024 By Trust
ALPINE IMMUNE SCIENCES, INC. Director, 10%+ Owner Stock Option (Right to buy) 70,000 15 Jul 2022 Direct
Elicio Therapeutics, Inc. Director Common Warrants 50,000 28 Jun 2024 Direct
Serina Therapeutics, Inc. Director Stock Option (right to buy) 10,000 07 Nov 2025 Direct
Elicio Therapeutics, Inc. Director Stock Option (Right to Buy) 7,900 19 May 2025 Direct
Elicio Therapeutics, Inc. Director Warrant to Purchase Common Stock 0 26 Nov 2024 Direct

Insider Reports Filed by Jay R. Venkatesan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SER Serina Therapeutics, Inc. 07 Nov 2025 1 $0 4 Director 10 Nov 2025, 19:57
ELTX Elicio Therapeutics, Inc. 19 May 2025 1 $0 4 Director 20 May 2025, 16:07
SER Serina Therapeutics, Inc. 08 Apr 2025 1 +$500,000 4 Director 10 Apr 2025, 16:03
SER Serina Therapeutics, Inc. 12 Feb 2025 1 $0 4 Director 13 Feb 2025, 17:03
SER Serina Therapeutics, Inc. 12 Feb 2025 0 $0 3 Director 13 Feb 2025, 17:02
ELTX Elicio Therapeutics, Inc. 26 Nov 2024 2 +$500 4 Director 29 Nov 2024, 07:39
ELTX Elicio Therapeutics, Inc. 21 Nov 2024 1 $0 4 Director 25 Nov 2024, 07:35
ELTX Elicio Therapeutics, Inc. 28 Jun 2024 2 +$249,500 4/A Director 02 Jan 2025, 16:05
ELTX Elicio Therapeutics, Inc. 28 Dec 2023 1 $0 4 Director 29 Dec 2023, 17:05
/report/000162619922000052-venkatesan-jay-2022-07-15 ALPINE IMMUNE SCIENCES, INC. 15 Jul 2022 2 $0 4 Director, 10%+ Owner 19 Jul 2022, 16:38
ELTX Angion Biomedica Corp. 25 May 2022 1 +$14,103 4 Officer, Director 27 May 2022, 16:18
ELTX Angion Biomedica Corp. 20 May 2022 2 +$101,428 4 President and Chief Executive Officer and Director, Director 25 May 2022, 17:58
ELTX Angion Biomedica Corp. 03 Mar 2022 2 $0 4 President and Chief Executive Officer 04 Mar 2022, 15:22
/report/000162619922000016-venkatesan-jay-2022-01-03 ALPINE IMMUNE SCIENCES, INC. 03 Jan 2022 1 $0 4 Director, 10%+ Owner 04 Jan 2022, 16:37
ELTX Angion Biomedica Corp. 27 Dec 2021 2 +$730,373 4 President and Chief Executive Officer and Director, Director 29 Dec 2021, 15:08
ELTX Angion Biomedica Corp. 20 Dec 2021 1 +$8,976 4 President and Chief Executive Officer and Director, Director 22 Dec 2021, 15:06
ELTX Angion Biomedica Corp. 16 Dec 2021 2 +$105,951 4 President and Chief Executive Officer and Director, Director 20 Dec 2021, 17:44
/report/000162619921000113-venkatesan-jay-2021-09-17 ALPINE IMMUNE SCIENCES, INC. 17 Sep 2021 1 -$3,760,000 4 Director, 10%+ Owner 21 Sep 2021, 17:14
ELTX Angion Biomedica Corp. 24 Jun 2021 2 -$379,278 4 President and Chief Executive Officer and Director, Director 17 Dec 2021, 16:13
ELTX Angion Biomedica Corp. 09 Feb 2021 4 +$4,595 4/A President and Chief Executive Officer and Director, Director 27 May 2022, 16:20